Jianling Xie - Concepedia

Author

Jianling Xie

South Australian Health and Medical Research Institute ORCID

Also Known As

J. Xie, Jianling Xie, Xie, Jianling

115

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

South Australian Health and Medical Research Institute The University of Adelaide University of Southampton Shanghai University of Traditional Chinese Medicine Flinders University

About

Jianling Xie is an author at South Australian Health and Medical Research Institute specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	19	1.1K
2	Natural Sciences	4	4	197
3	Biochemistry	2	2	51
4	Public Health	1	1	66
5	Social Sciences	1	1	20

Jianling Xie

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
mTOR inhibitors in cancer therapy Jianling Xie, Xuemin Wang, Christopher G. Proud F1000Research Mtor Complexes 1PharmacotherapyTumor BiologyOncologyReceptor Tyrosine Kinase	2016	263
Eukaryotic Elongation Factor 2 Kinase Activity Is Controlled by Multiple Inputs from Oncogenic Signaling Xuemin Wang, Sergio Regufe da Mota, Rui Liu, Molecular and Cellular Biology Mtorc1 And/or ErkTumor BiologyTranscriptional RegulationSignaling PathwayCell Regulation	2014	102
Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan Jianling Xie, Viviane S. Alves, Tobias von der Haar, Current Biology Protein FunctionDevelopmental BiologyProtein ExpressionProtein FoldingNatural Sciences	2019	81
mTORC1 Plays an Important Role in Skeletal Development by Controlling Preosteoblast Differentiation Stephen Fitter, Mary P. Matthews, Sally K. Martin, Molecular and Cellular Biology	2017	75
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2) Adam D. Barlow, Jianling Xie, Claire E. Moore, Diabetologia	2012	74
cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity Jianling Xie, Godwin A. Ponuwei, Claire E. Moore, Cellular Signalling	2011	69
The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding James E. Beggs, Shuye Tian, Greg G. Jones, Biochemical Journal Vimentin ExpressionVimentin ProteinCytoskeletonCellular PhysiologySignaling Pathway	2015	66
Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma <i>via</i> PI3K/Akt and STAT3 Ying Zhou, Yaoting Li, Shihao Xu, International Journal of Cancer Kinase PromotesCancer ResearchTranscriptional RegulationAngiogenesisMedicine	2019	66
The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life Miriam A. Lynn, Georgina L. Eden, Feargal J. Ryan, Cell Reports Microbiota StructureDysbiosisPam IiMedicinePost-antibiotic Microbiota	2021	66
Identification of cAMP-Dependent Kinase as a Third in Vivo Ribosomal Protein S6 Kinase in Pancreatic β-Cells Claire E. Moore, Jianling Xie, Edith Gomez, Journal of Molecular Biology Pancreatic β-CellsCamp-dependent KinaseSignal TransductionMolecular PhysiologyCell Regulation	2009	54

Page 1